These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 32277002)

  • 1. Evaluating Discrimination of a Lung Cancer Risk Prediction Model Using Partial Risk-Score in a Two-Phase Study.
    Pal Choudhury P; Chaturvedi AK; Chatterjee N
    Cancer Epidemiol Biomarkers Prev; 2020 Jun; 29(6):1196-1203. PubMed ID: 32277002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implications of Nine Risk Prediction Models for Selecting Ever-Smokers for Computed Tomography Lung Cancer Screening.
    Katki HA; Kovalchik SA; Petito LC; Cheung LC; Jacobs E; Jemal A; Berg CD; Chaturvedi AK
    Ann Intern Med; 2018 Jul; 169(1):10-19. PubMed ID: 29800127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and Validation of Risk Models to Select Ever-Smokers for CT Lung Cancer Screening.
    Katki HA; Kovalchik SA; Berg CD; Cheung LC; Chaturvedi AK
    JAMA; 2016 Jun; 315(21):2300-11. PubMed ID: 27179989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Exploratory research on developing lung cancer risk prediction model in female non-smokers].
    Lyu ZY; Li N; Chen SH; Wang G; Tan FW; Feng XS; Li X; Wen Y; Yang ZY; Wang YL; Li J; Chen HD; Lin CQ; Ren JS; Shi JF; Wu SL; Dai M; He J
    Zhonghua Yu Fang Yi Xue Za Zhi; 2020 Nov; 54(11):1261-1267. PubMed ID: 33147927
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of Prediction Models for Identifying Malignancy in Pulmonary Nodules Detected via Low-Dose Computed Tomography.
    González Maldonado S; Delorme S; Hüsing A; Motsch E; Kauczor HU; Heussel CP; Kaaks R
    JAMA Netw Open; 2020 Feb; 3(2):e1921221. PubMed ID: 32058555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk prediction models for selection of lung cancer screening candidates: A retrospective validation study.
    Ten Haaf K; Jeon J; Tammemägi MC; Han SS; Kong CY; Plevritis SK; Feuer EJ; de Koning HJ; Steyerberg EW; Meza R
    PLoS Med; 2017 Apr; 14(4):e1002277. PubMed ID: 28376113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifying high risk individuals for targeted lung cancer screening: Independent validation of the PLCO
    Weber M; Yap S; Goldsbury D; Manners D; Tammemagi M; Marshall H; Brims F; McWilliams A; Fong K; Kang YJ; Caruana M; Banks E; Canfell K
    Int J Cancer; 2017 Jul; 141(2):242-253. PubMed ID: 28249359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating Inflammation Markers, Risk of Lung Cancer, and Utility for Risk Stratification.
    Shiels MS; Katki HA; Hildesheim A; Pfeiffer RM; Engels EA; Williams M; Kemp TJ; Caporaso NE; Pinto LA; Chaturvedi AK
    J Natl Cancer Inst; 2015 Oct; 107(10):. PubMed ID: 26220734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Novel Pathway-Based Approach Improves Lung Cancer Risk Prediction Using Germline Genetic Variations.
    Qian DC; Han Y; Byun J; Shin HR; Hung RJ; McLaughlin JR; Landi MT; Seminara D; Amos CI
    Cancer Epidemiol Biomarkers Prev; 2016 Aug; 25(8):1208-15. PubMed ID: 27222311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Individual and joint contributions of genetic and methylation risk scores for enhancing lung cancer risk stratification: data from a population-based cohort in Germany.
    Yu H; Raut JR; Schöttker B; Holleczek B; Zhang Y; Brenner H
    Clin Epigenetics; 2020 Jun; 12(1):89. PubMed ID: 32552915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a risk prediction model for lung cancer: The Japan Public Health Center-based Prospective Study.
    Charvat H; Sasazuki S; Shimazu T; Budhathoki S; Inoue M; Iwasaki M; Sawada N; Yamaji T; Tsugane S;
    Cancer Sci; 2018 Mar; 109(3):854-862. PubMed ID: 29345859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Robust risk prediction with biomarkers under two-phase stratified cohort design.
    Payne R; Yang M; Zheng Y; Jensen MK; Cai T
    Biometrics; 2016 Dec; 72(4):1037-1045. PubMed ID: 27037494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cumulative nonsmoking risk factors increase the probability of developing lung cancer.
    Bravo-Iñiguez CE; Fox SW; De Leon LE; Tarascio JN; Jaklitsch MT; Jacobson FL
    J Thorac Cardiovasc Surg; 2019 Oct; 158(4):1248-1254.e1. PubMed ID: 31248631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Body mass index and cancer incidence:a prospective cohort study in northern China].
    Guo L; Li N; Wang G; Su K; Li F; Yang L; Ren J; Chang S; Chen S; Wu S; He J; Dai M
    Zhonghua Liu Xing Bing Xue Za Zhi; 2014 Mar; 35(3):231-6. PubMed ID: 24831616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IMPROVING EFFICIENCY IN BIOMARKER INCREMENTAL VALUE EVALUATION UNDER TWO-PHASE DESIGNS.
    Zheng Y; Brown M; Lok A; Cai T
    Ann Appl Stat; 2017 Jun; 11(2):638-654. PubMed ID: 28943991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and Validation of a Multivariable Lung Cancer Risk Prediction Model That Includes Low-Dose Computed Tomography Screening Results: A Secondary Analysis of Data From the National Lung Screening Trial.
    Tammemägi MC; Ten Haaf K; Toumazis I; Kong CY; Han SS; Jeon J; Commins J; Riley T; Meza R
    JAMA Netw Open; 2019 Mar; 2(3):e190204. PubMed ID: 30821827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting Lung Cancer Occurrence in Never-Smoking Females in Asia: TNSF-SQ, a Prediction Model.
    Chien LH; Chen CH; Chen TY; Chang GC; Tsai YH; Hsiao CF; Chen KY; Su WC; Wang WC; Huang MS; Chen YM; Chen CY; Liang SK; Chen CY; Wang CL; Lee MH; Chung RH; Tsai FY; Hu JW; Katki HA; Chatterjee N; Chanock SJ; Rothman N; Lan Q; Yang PC; Chen CJ; Chang IS; Hsiung CA
    Cancer Epidemiol Biomarkers Prev; 2020 Feb; 29(2):452-459. PubMed ID: 31848206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Participant selection for lung cancer screening by risk modelling (the Pan-Canadian Early Detection of Lung Cancer [PanCan] study): a single-arm, prospective study.
    Tammemagi MC; Schmidt H; Martel S; McWilliams A; Goffin JR; Johnston MR; Nicholas G; Tremblay A; Bhatia R; Liu G; Soghrati K; Yasufuku K; Hwang DM; Laberge F; Gingras M; Pasian S; Couture C; Mayo JR; Nasute Fauerbach PV; Atkar-Khattra S; Peacock SJ; Cressman S; Ionescu D; English JC; Finley RJ; Yee J; Puksa S; Stewart L; Tsai S; Haider E; Boylan C; Cutz JC; Manos D; Xu Z; Goss GD; Seely JM; Amjadi K; Sekhon HS; Burrowes P; MacEachern P; Urbanski S; Sin DD; Tan WC; Leighl NB; Shepherd FA; Evans WK; Tsao MS; Lam S;
    Lancet Oncol; 2017 Nov; 18(11):1523-1531. PubMed ID: 29055736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variations in lung cancer risk among smokers.
    Bach PB; Kattan MW; Thornquist MD; Kris MG; Tate RC; Barnett MJ; Hsieh LJ; Begg CB
    J Natl Cancer Inst; 2003 Mar; 95(6):470-8. PubMed ID: 12644540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating classification performance of biomarkers in two-phase case-control studies.
    Wang L; Huang Y
    Stat Med; 2019 Jan; 38(1):100-114. PubMed ID: 30209824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.